Natalie Munk - 07 Feb 2025 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Chief Accounting Officer
Signature: By: Justin Hunter For: Natalie Munk
Issuer symbol: MYGN
Transactions as of: 07 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2025, 19:32:01 UTC
Previous filing: 23 Sep 2024
Next filing: 17 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Award	$0	+3,316	+7.7%	$0.000000	46,575	07 Feb 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.

Content

Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.